Skip to main content
Signal8

Luo Ying

SEC insider (Form 3/4/5 filer). CIK 0001959160. Chief Executive Officer at GYRE THERAPEUTICS, INC. (GYRE). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 8, 2026. Located in SAN DIEGO, CA.

Companies Luo Ying has filed insider reports for

  • GYRE THERAPEUTICS, INC. (GYRE): Director, Officer, Chief Executive Officer
Luo Ying profile photo

Luo Ying

CIK: 0001959160

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GYRE THERAPEUTICS, INC. logo
GYRE

GYRE THERAPEUTICS, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • GYRE THERAPEUTICS, INC. logo
    GYRE

    GYRE THERAPEUTICS, INC.

    Jun 8, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    120K shares-
  • GYRE THERAPEUTICS, INC. logo
    GYRE

    GYRE THERAPEUTICS, INC.

    May 6, 2026
    Sale
    Indirect
    10.1K shares at avg. $8.04$81K
  • GYRE THERAPEUTICS, INC. logo
    GYRE

    GYRE THERAPEUTICS, INC.

    May 5, 2026
    Sale
    Indirect
    179 shares at avg. $8.01$1K

1-3 of 3